2-(1-Propenyl)-3,4,5,6-tetrahydropyridine

Details

Top
Internal ID 9a0f8170-cd3e-470d-b83a-55238dcadf37
Taxonomy Organoheterocyclic compounds > Pyridines and derivatives > Hydropyridines > Tetrahydropyridines
IUPAC Name 6-[(E)-prop-1-enyl]-2,3,4,5-tetrahydropyridine
SMILES (Canonical) CC=CC1=NCCCC1
SMILES (Isomeric) C/C=C/C1=NCCCC1
InChI InChI=1S/C8H13N/c1-2-5-8-6-3-4-7-9-8/h2,5H,3-4,6-7H2,1H3/b5-2+
InChI Key SOEACRLLVZHBKW-GORDUTHDSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C8H13N
Molecular Weight 123.20 g/mol
Exact Mass 123.104799419 g/mol
Topological Polar Surface Area (TPSA) 12.40 Ų
XlogP 1.20
Atomic LogP (AlogP) 2.19
H-Bond Acceptor 1
H-Bond Donor 0
Rotatable Bonds 1

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of 2-(1-Propenyl)-3,4,5,6-tetrahydropyridine

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9822 98.22%
Caco-2 + 0.9501 95.01%
Blood Brain Barrier + 1.0000 100.00%
Human oral bioavailability + 0.8000 80.00%
Subcellular localzation Lysosomes 0.4320 43.20%
OATP2B1 inhibitior - 0.8553 85.53%
OATP1B1 inhibitior + 0.9449 94.49%
OATP1B3 inhibitior + 0.9506 95.06%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior + 0.5500 55.00%
BSEP inhibitior - 0.9626 96.26%
P-glycoprotein inhibitior - 0.9926 99.26%
P-glycoprotein substrate - 0.9424 94.24%
CYP3A4 substrate - 0.6569 65.69%
CYP2C9 substrate - 0.8052 80.52%
CYP2D6 substrate - 0.8530 85.30%
CYP3A4 inhibition - 0.9651 96.51%
CYP2C9 inhibition - 0.9333 93.33%
CYP2C19 inhibition - 0.8900 89.00%
CYP2D6 inhibition - 0.7766 77.66%
CYP1A2 inhibition - 0.5323 53.23%
CYP2C8 inhibition - 0.9579 95.79%
CYP inhibitory promiscuity - 0.9237 92.37%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.8400 84.00%
Carcinogenicity (trinary) Non-required 0.6223 62.23%
Eye corrosion + 0.9658 96.58%
Eye irritation + 0.9740 97.40%
Skin irritation + 0.7555 75.55%
Skin corrosion + 0.9469 94.69%
Ames mutagenesis - 0.7970 79.70%
Human Ether-a-go-go-Related Gene inhibition - 0.5096 50.96%
Micronuclear - 0.8900 89.00%
Hepatotoxicity + 0.5803 58.03%
skin sensitisation - 0.5630 56.30%
Respiratory toxicity + 0.6222 62.22%
Reproductive toxicity - 0.7778 77.78%
Mitochondrial toxicity + 0.6125 61.25%
Nephrotoxicity - 0.6622 66.22%
Acute Oral Toxicity (c) III 0.6906 69.06%
Estrogen receptor binding - 0.9480 94.80%
Androgen receptor binding - 0.8959 89.59%
Thyroid receptor binding - 0.8421 84.21%
Glucocorticoid receptor binding - 0.7454 74.54%
Aromatase binding - 0.7952 79.52%
PPAR gamma - 0.8660 86.60%
Honey bee toxicity - 0.9358 93.58%
Biodegradation - 0.5750 57.50%
Crustacea aquatic toxicity + 0.7100 71.00%
Fish aquatic toxicity - 0.6229 62.29%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL2581 P07339 Cathepsin D 86.59% 98.95%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 84.35% 95.56%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 81.88% 96.09%
CHEMBL3192 Q9BY41 Histone deacetylase 8 81.10% 93.99%

Cross-Links

Top
PubChem 15937508
NPASS NPC168636
LOTUS LTS0138408
wikiData Q105256886